The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)

Documenti analoghi

• Pathways to Improved Antibiotic Allergy and Antimicrobial Stewardship Practice - The Validation of a Beta-Lactam Antibiotic Allergy Assessment Tool
  di: Devchand, Misha, et al.
  Pubblicazione: (2018)
• Coronavirus Disease 2019 Treatment: It is Time for Stewardship!
  di: Nasa, Prashant
  Pubblicazione: (2020)
• Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
  di: Lippi, Giuseppe, et al.
  Pubblicazione: (2020)
• Impact of the strategies implemented by an antimicrobial stewardship program on the antibiotic consumption in the coronavirus disease 2019 (COVID-19) pandemic
  di: Murgadella-Sancho, Anna, et al.
  Pubblicazione: (2021)
• Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
  di: Drewett, George P., et al.
  Pubblicazione: (2021)